申请人:Bayer Aktiengesellschaft
公开号:US04052409A1
公开(公告)日:1977-10-04
Imidazoles of the formula ##STR1## and pharmaceutically acceptable nontoxic salts thereof, wherein X is methyl or chloro, Y is methyl or chloro, or, when Z is methyl or chloro, Y is hydrogen, and Z is methyl or chloro, or, when Y is methyl or chloro, Z is hydrogen, Are useful as antimycotics for the treatment of mycotic infections in humans and animals. The imidazoles may be produced by reacting the corresponding triphenylmethylcarbinol with a brominating or chlorinating agent and thereafter reacting the resultant triphenylmethyl halide, either with or without isolation, with imidazole in the presence or absence of an acid-binding agent, or they may be prepared by reacting a triphenylmethyl halide with imidazole, either in the presence or absence of an acid-binding agent.
式为##STR1##的咪唑及其药学上可接受的无毒盐,其中X为甲基或氯,Y为甲基或氯,或者当Z为甲基或氯时,Y为氢,Z为甲基或氯,或者当Y为甲基或氯时,Z为氢。它们可用作抗真菌药物,用于治疗人类和动物的真菌感染。咪唑可以通过将相应的三苯甲基甲醇与溴化或氯化试剂反应,并在酸中和或不和隔离的情况下将所得的三苯甲基卤化物与咪唑反应而制备,或者可以通过将三苯甲基卤化物与咪唑在存在或不存在酸结合剂的情况下反应而制备。